Mauskopf J, Paramore C, Lee WC, McBurney CR, Snyder EH. Drug persistence is similar with rivastigmine and donepezil in Alzheimer's disease patients. Neurobiol Aging. 2004 Jan 1;25:S204.
Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.
Ofman J, Hauber B, Deal L, Mauskopf J, Snyder E. Costs and benefits of rivastigmine treatment for Alzheimer's disease in the US. Neurobiol Aging. 2002 Jan 1;23(1):476.
Freund DA, Hurley RE, Adamache KW, Mauskopf J. The performance of urban and public hospitals and NHCs (neighborhood health centers) under Medicaid capitation programs. Hosp Health Serv Adm. 1990 Jan 1;35(4):525-46.